Fig. 1From: The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumorsThe types and frequencies of MDM2 alterations in different malignancies (cBioportal for Cancer Genomics). A lung cancer, B colorectal cancer, C livercancer, D breast cancer; E esophagogastric cancerBack to article page